scholarly journals The Uptake of Screening for Type 2 Diabetes and Prediabetes by Means of Glycated Hemoglobin versus the Oral Glucose Tolerance Test among 18 to 60-Year-Old People of South Asian Origin: A Comparative Study

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0136734 ◽  
Author(s):  
Irene G. M. van Valkengoed ◽  
Everlina M. A. Vlaar ◽  
Vera Nierkens ◽  
Barend J. C. Middelkoop ◽  
Karien Stronks
Keyword(s):  
South Asian ◽  
Glucose Tolerance Test ◽  
Glycated Hemoglobin ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance ◽  
Old People ◽  
Asian Origin ◽  
South Asian Origin

Diabetology for primary health care – the use of metformin in the treatment of prediabetes, primary prevention and secondary prevention in type 2 diabetes

2021 ◽  
Vol 14 (4) ◽  
pp. 346-348
Author(s):  
Grzegorz Dzida
Keyword(s):  
Type 2 Diabetes ◽  
Health Care ◽  
Glucose Tolerance Test ◽  
Glycated Hemoglobin ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Oral Glucose Tolerance ◽  
Primary Health ◽  
New Criterion

The 2021 guidelines on the management of diabetes by the Polish Diabetes Association introduce the new criterion for the diagnosis of diabetes – percentage of glycated hemoglobin HbA1c > 6.5%. This is important, especially now, during the COVID-19 epidemic, for patients with diagnosed pre-diabetes who are already using metformin, as it allows to release the need for an oral glucose tolerance test. The article describes the principles of using metformin in the prevention of type 2 diabetes.

scholarly journals Antidiabetic Effects of Add-OnGynostemma pentaphyllumExtract Therapy with Sulfonylureas in Type 2 Diabetic Patients

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
V. T. T. Huyen ◽  
D. V. Phan ◽  
P. Thang ◽  
P. T. Ky ◽  
N. K. Hoa ◽  
...  
Keyword(s):  
Glucose Tolerance Test ◽  
Tolerance Test ◽  
Oral Glucose ◽  
Diabetic Patients ◽  
Oral Glucose Tolerance ◽  
Type 2 Diabetic Patients ◽  
Drug Naïve ◽  
Type 2 Diabetic ◽  
Antidiabetic Effects

Aims.To investigate the antidiabetic effect of the traditional Vietnamese herbGynostemma pentaphyllum(GP) together with sulfonylurea (SU) in 25 drug-naïve type 2 diabetic patients.Methods.After 4-week treatment with gliclazide (SU), 30 mg daily, all patients were randomly assigned into 2 groups to add on GP extract or placebo extract, 6 g daily, during eight weeks.Results.After 4-week SU treatment, fasting plasma glucose (FPG) and HbA1Cdecreased significantly (P<0.001). FPG was further reduced after add-on therapy with 2.9 ± 1.7 and 0.9 ± 0.6 mmol/L in the GP and placebo groups, respectively (P<0.001). Therapy with GP extract also reduced 30- and 120-minute oral glucose tolerance test postload values. HbA1Clevels decreased approximately 2% units in the GP group compared to 0.7% unit in the placebo group (P<0.001).Conclusion.GP extract in addition to SU offers an alternative to addition of other oral medication to treat type 2 diabetic patients.

Sign in / Sign up

Export Citation Format

Share Document